US-based Carta Healthcare has announced the closing of its series B financing, raising $25m to scale operations.
Memorial Hermann Health System and UnityPoint Health have made additional investments in the company to help simplify data abstraction while delivering data insights to drive quality improvement.
The recent round of funding follows the initial series B financing of $20m, which was disclosed in November last year.
Investors in that round included Paramark Ventures, the American College of Cardiology, Frist Cressey Ventures, Asset Management Ventures, Mass General Brigham, CU Healthcare Innovation Fund, Storm Ventures, and Maverick Ventures Investment Fund.
Carta Healthcare co-founder and CEO Matt Hollingsworth said: “This funding will allow us to scale operations and product development, making more products accessible to more health systems.”
Carta Healthcare specialises in collecting, analysing, and providing insights into clinical data.
With advanced technology and a team of experienced clinicians, the company offers quality registry data abstraction, analytics, and reporting to healthcare systems across the country.
By streamlining the data abstraction process and implementing analytic capabilities, Carta Healthcare enables data-driven, decision-making for improved patient outcomes, cost savings in data processing, and an increased focus on patient care for healthcare professionals.
Memorial Hermann executive vice-president and chief strategy officer Feby Abraham said: “Memorial Hermann invests in solutions that align with our vision to create healthier communities.
“Carta’s platform gives providers and researchers access to timely, actionable analytics and insights that can lead to meaningful quality improvements and enhanced research capabilities.”
The post Carta Healthcare raises funding to scale operations appeared first on Hospital Management.